Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session

Published 18/11/2022, 18:15
Updated 18/11/2022, 19:44

Benzinga - Gainers

  • PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
  • Satixfy Communications Ltd. (NYSE: SATX) rose 53.2% to $79.20.
  • 1847 Holdings LLC (NYSE: EFSH) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million.
  • IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy.
  • Clearfield, Inc. (NASDAQ: CLFD) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results.
  • Yatra Online, Inc. (NASDAQ: YTRA) shares jumped 24.1% to $2.6299. Yatra Online's Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022.
  • Conformis, Inc. (NASDAQ: CFMS) gained 23.6% to $1.9540. Conformis, on Thursday, reported the full commercial launch of its new Imprint™ knee system.
  • Muscle Maker, Inc. (NASDAQ: GRIL) surged 23.1% to $0.3819. Muscle Maker announced vertical integration initiative with AGGIA LLC FZ.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) jumped 20.8% to $52.27 after the company announced FDA acceptance of the company's NDA amendment and new PDUFA date of February 26, 2023 for pegcetacoplan for geographic atrohpy.
  • StoneCo Ltd. (NASDAQ: STNE) rose 17.7% to $11.62 after the company reported Q3 results.
  • Sculptor Capital Management, Inc. (NYSE: SCU) gained 16.6% to $9.90. Sculptor Capital Management's independent Directors announced formation of special committee to explore potential transactions.
  • Horizon Global Corporation (NYSE: HZN) jumped 15.4% to $0.60. Horizon Global recently posted a Q3 loss of $0.92 per share.
  • Ardelyx, Inc. (NASDAQ: ARDX) gained 15% to $1.9890. Ardelyx recently announced the FDA Advisory Committee voted 9-to-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
  • Evolent Health, Inc. (NYSE: EVH) jumped 14.4% to $27.30. Evolent Health agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene (NYSE:CNC).
  • Open Lending Corporation (NASDAQ: LPRO) jumped 13.6% to $7.62. Open Lending’s Board Of Directors authorized $75 million share repurchase program.
  • Ross Stores (NASDAQ:ROST), Inc. (NASDAQ: ROST) rose 12.6% to $110.33 after the company reported better-than-expected Q3 results and issued strong earnings guidance.
  • Atkore Inc. (NYSE: ATKR) gained 12.8% to $113.50 after the company posted upbeat Q4 results and issued strong Q1 earnings forecast.
  • Ambarella, Inc. (NASDAQ: AMBA) jumped 12.2% to $74.99.
  • indie Semiconductor, Inc. (NASDAQ: INDI) gained 11.6% to $7.52. Indie Semiconductor priced $140 million aggregate principal amount of its 4.500% Convertible Senior Notes due 2027 via a private institutional offering.
  • Foot Locker (NYSE:FL), Inc. (NYSE: FL) gained 11% to $36.63 after the company reported better-than-expected Q3 adjusted EPS and sales results and raised FY22 guidance.
  • Ryan Specialty Holdings, Inc. (NYSE: RYAN) gained 10% to $38.08. Patrick G Ryan, Chief Executive Officer at Ryan Specialty Holdings, reported a large insider buy on November 17, according to a new SEC filing
  • FingerMotion, Inc. (NASDAQ: FNGR) jumped 9.6% to $5.59.
  • The Gap, Inc. (NYSE: GPS) rose 8.6% to $13.81 after the company reported better-than-expected Q3 sales results.
  • Biora Therapeutics, Inc. (NASDAQ: BIOR) rose 8.4% to $0.2495 after dropping 8% on Thursday. Biora Therapeutics recently posted a Q3 loss of $0.08 per share.
  • Palo Alto (NASDAQ:PANW) Networks, Inc. (NASDAQ: PANW) rose 8.1% to $169.23 after the company reported better-than-expected results for its second quarter and issued strong FY23 earnings guidance. The company also announced plans to acquire Cider Security for approximately $195 million.
  • Burlington Stores, Inc. (NYSE: BURL) gained 7.4% to $162.15.
  • Quhuo Limited (NASDAQ: QH) rose 7.2% to $1.78. Quhuo recently reported better-than-expected H1 results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • TuanChe Limited (NASDAQ: TC) shares dipped 38.1% to $5.76. TuanChe and IAT Automobile Technology Co., Ltd., on Thursday, announced a strategic partnership to develop and market new energy vehicles.
  • Scilex Holding Company (NASDAQ: SCLX) shares fell 35% to $6.07 after gaining over 6% on Thursday.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) fell 33% to $3.99. Kiora Pharmaceuticals entered into agreements to raise $3.12 million from the exercise of previously issued Class A warrants.
  • Inotiv, Inc. (NASDAQ: NOTV) dropped 29.8% to $4.79. Lake Street downgraded Inotiv from Buy to Hold and announced a $7 price target. Inotiv, on Thursday, announced the U.S. Attorney's Office for the Southern District of Florida has criminally charged employees of the co.'s principal supplier of non-human primates, along with two Cambodian officials, with conspiring to illegally import non-human primates into the U.S.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) fell 24% to $6.50 after the company reported pricing of $50.05 million public offering of 7.7 million shares of common stock at a price of $6.50 per share.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) dropped 21% to $3.03 after the company announced a $6 million private placement priced at a premium to the market.
  • CN Energy Group. Inc. (NASDAQ: CNEY) declined 19.4% to $1.99.
  • Delta Apparel, Inc. (NYSE: DLA) dropped 16.1% to $14.02. Delta Apparel posted a Q4 loss of $0.04 per share.
  • TRxADE HEALTH, Inc. (NASDAQ: MEDS) declined 15.2% to $0.5679. Trxade Health recently posted a Q3 loss of $0.06 per share.
  • Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) dropped 15% to $10.15 following downbeat Q4 results.
  • Rent the Runway, Inc. (NASDAQ: RENT) dropped 14.5% to $1.2315. Morgan Stanley (NYSE:MS) downgraded Rent the Runway from Overweight to Equal-Weight and lowered the price target from $10 to $2.5.
  • Farfetch Limited (NYSE: FTCH) fell 14.3% to $7.80 after the company reported worse-than-expected Q3 revenues. Gross merchandise value decreased 4.9% year over year.
  • GoHealth, Inc. (NASDAQ: GOCO) dropped 13.7% to $8.02. CCP III Cayman GP Ltd., 10% Owner at GoHealth, reported a large insider buy on November 17, according to a new SEC filing.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 13% to $2.21 after dropping 9% on Thursday.
  • Vertex (NASDAQ:VRTX), Inc. (NASDAQ: VERX) dropped 12.8% to $14.73. Vertex priced 1.5 million shares by Jeffrey R. Westphal at $15.15 per share via a secondary public offering.
  • Concord Medical Services Holdings Limited (NYSE: CCM) dipped 11.5% to $1.38.
  • Freight Technologies, Inc. (NASDAQ: FRGT) declined 11.4% to $0.3024.
  • American Software, Inc. (NASDAQ: AMSWA) fell 11.2% to $14.49 after the company posted downbeat Q2 sales and issued weak sales forecast.
  • Cuentas Inc. (NASDAQ: CUEN) fell 9.3% to $0.2889 after jumping 28% on Thursday.
  • Zhihu Inc. (NYSE: ZH) fell 5.6% to $1.2850. Zhihu is expected to report Q3 financial results on November 30, 2022.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.